GlaxoSmithKline PLC at JPMorgan Healthcare Conference Transcript
Good morning. I'm James Gordon, JPMorgan European pharma and biotech analyst. And today, I've got the pleasure of introducing the GSK presentation. So you're going to hear from GSK CEO, Emma Walmsley, and we're going to have a breakout behind this room in the Borgia afterwards. So I hope you can join us for the Q&A. So with that said, thanks very much for joining us and look forward to the presentation.
Good morning, everybody, and thank you very much, James. Thanks to you all for joining us here early this morning. So first of all, let me just refer you to our cautionary statement.
When I became CEO of GSK in 2017, I laid out my 3 long-term priorities for the company: innovation, performance and trust, all to be powered by a necessary change in culture. Initially, it was simply a framework. And though there remains much more to do, we're now demonstrating good progress on these priorities.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
